oral semaglutide launch Novo Nordisk has received FDA approval for Wegovy® (semaglutide) 25 mg, taken once daily, making it the first oral GLP-1 drug approved for obesity. Based on OASIS and SELECT trials, it With the launch of our
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3









:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)














